You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

interleukin-7

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

Mycobacterium Infections, Nontuberculous Trial in Saint Louis (Recombinant human interleukin-7)

Recruiting
  • Mycobacterium Infections, Nontuberculous
  • Recombinant human interleukin-7
  • Saint Louis, Missouri
    Washington University
Mar 30, 2022

Interleukin-7 Serum Level as Biological Marker in Breast Cancer

Completed
  • Breast Cancer Invasive
    • Pristina, Kosovo
      Faton I. Sermaxhaj, MD
    Mar 18, 2022

    COVID-19, Lymphocytopenia Trial in Brazil (Interleukin-7, PLACEBO)

    Terminated
    • COVID-19
    • Lymphocytopenia
    • Interleukin-7
    • PLACEBO
    • Porto Alegre, RIO Grande DO SUL, Brazil
    • +5 more
    Mar 30, 2022

    COVID-19, Lymphocytopenia Trial in United Kingdom (Interleukin-7, Placebos)

    Terminated
    • COVID-19
    • Lymphocytopenia
    • Interleukin-7
    • Placebos
    • Birmingham, United Kingdom
    • +12 more
    Mar 30, 2022

    Sepsis, Severe Trial in France, United States (CYT107, Placebos)

    Terminated
    • Sepsis, Severe
    • CYT107
    • Placebos
    • Gainesville, Florida
    • +9 more
    Oct 19, 2021

    COVID-19, SARS-CoV-2 Trial (NT-I7, Placebo, Blood for research purposes)

    Withdrawn
    • COVID-19
    • SARS-CoV-2
    • (no location specified)
    Jul 29, 2021

    Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human

    Not yet recruiting
    • Idiopathic CD4 Lymphopenia
    • Recombinant human interleukin (IL) 7-hyFc
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

    Recruiting
    • Advanced Bladder Urothelial Carcinoma
    • +23 more
    • Riverside, California
    • +8 more
    Jul 16, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Cytokine-Induced Memory-like Natural Killer Cells
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Nov 22, 2023

    Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

    Completed
    Has Results
    • Stage III Cutaneous Melanoma AJCC v7
    • +5 more
    • Aldesleukin
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2022

    Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

    Recruiting
    • Solid Tumor
    • Wuhan, Hubei, China
      Wuhan Union Hospital
    May 31, 2023

    Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

    Active, not recruiting
    Has Results
    • Clear Cell Renal Cell Carcinoma
    • +3 more
    • Aldesleukin
    • +6 more
    • Los Angeles, California
    • +3 more
    Nov 16, 2022

    Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

    Active, not recruiting
    • Metastatic Melanoma
    • +2 more
    • Aldesleukin
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Cervical Cancer, Anal Cancer, Head Neck Cancers Trial in Zhengzhou (Fludarabine + Cyclophosphamide, Interleukin-2, CRTE7A2-01

    Recruiting
    • Cervical Cancer
    • +2 more
    • Fludarabine + Cyclophosphamide
    • +2 more
    • Zhengzhou, Henan, China
      The First Affiliated Hospital of Zhengzhou University
    Jun 22, 2022

    Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

    Completed
    • Metastatic Melanoma
    • +3 more
    • Aldesleukin
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 27, 2022

    COVID-19 Trial in Halifax (Baricitinib (janus kinase inhibitor), Remdesivir (antiviral) + barictinib (janus kinase inhibitor),

    Recruiting
    • COVID-19
    • Baricitinib (janus kinase inhibitor)
    • +3 more
    • Halifax, Nova Scotia, Canada
      Nova Scotia Health Authority
    Mar 9, 2022

    Severe Sepsis With Septic Shock Trial in Nashville (Interleukin-7, Placebo)

    Completed
    Has Results
    • Severe Sepsis With Septic Shock
    • Interleukin-7
    • Placebo
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jul 8, 2020

    Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

    Active, not recruiting
    • Metastatic Melanoma
    • Stage IV Cutaneous Melanoma AJCC v6 and v7
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

    Terminated
    Has Results
    • Advanced Pleural Malignant Mesothelioma
    • +10 more
    • Aldesleukin
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 16, 2021

    Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

    Active, not recruiting
    • Human Papillomavirus-16 Positive
    • +20 more
    • DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
    • Durvalumab
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 11, 2022

    Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

    Recruiting
    • Subarachnoid Hemorrhage
    • Plymouth, Devon, United Kingdom
    • +11 more
    May 16, 2022

    Coronavirus Disease(COVID)-19 Acute Respiratory Distress

    Recruiting
    • COVID
    • Acute Respiratory Distress Syndrome
    • Angiotensin II
    • Interleukin-1 receptor antagonist
    • London, United Kingdom
      Guy's & St Thomas' Hospital
    Aug 3, 2021

    Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

    Recruiting
    • Metastatic Melanoma
    • +5 more
    • Aldesleukin
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 10, 2020

    Psoriatic Arthritis Trial in Germany, Netherlands, United Kingdom (AIN457A, Other)

    Completed
    Has Results
    • Psoriatic Arthritis
    • AIN457A
    • Other
    • Hamburg, Germany
    • +5 more
    May 26, 2021